Skip to main content
OpenTrials
Completed

NCT Number: NCT00359996

Improving Diabetes Care Collaboratively in the Community

The purpose of this study is to determine whether a quality improvement intervention including rapid quality improvement, a chronic care model, and best practices improves diabetes care in community health centers and whether more intensive interventions enhance care further.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Chicago

Chicago, Illinois, 60637, United States

About this study

In 1998 the Health Resources and Services Administration's Bureau of Primary Health Care began the Health Disparities Collaborative (HDC) to improve chronic disease management in community health centers (HC) nationwide. The HDC incorporates rapid quality improvement (QI), a chronic care model, and best practices. This study determines if the HDC improves diabetes care and whether more intensive interventions with additional learning sessions for health centers, provider training in behavioral change, and patient empowerment materials enhance care further.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with diabetes age 18-75 years

Exclusion criteria

Pregnant women

-

Treatment and study plan

health disparities collaborative

Behavioral

The HDC incorporates rapid quality improvement (QI), a chronic care model, and best practices. This study determines if the HDC improves diabetes care and whether more intensive interventions with additional learning sessions for health centers, provider training in behavioral change, and patient empowerment materials enhance care further.

No additional educational sessions

Other

Primary outcomes

  1. hemoglobin A1c

    Time frame: 4 years

    Change in hemoglobin A1c from baseline

Secondary outcomes

  1. Lipid levels

    Time frame: 4 years

    Change in Lipid blood levels from baseline

  2. Blood pressure

    Time frame: 4 years

    Change in BP from baseline

  3. Urine microalbumin levels

    Time frame: 4 years

    Change in urine micralbumin levels from baseline

Sponsors and collaborators

Lead sponsor

University of Chicago

Other

Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)
  • Robert Wood Johnson Foundation

Registry information

Important dates

Study start
2000
Primary completion
2006
Study completion
2006
First posted
Aug 3, 2006
Registry last updated
Apr 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.